Congratulations to Dr. Patrick Soon-Shiong and the ImmunityBio team! On July 4, 2025, the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) announced that they approved nogapendekin alfa inbakicept (Anktiva) for adults with BCG-unresponsive non-muscle

Wow- the power of news spread in today’s world! I just received the notice this am and amazingly it’s already on X!!! Yes we will work with agencies on a global basis that have the interest of their people rather than being captured by big pharma and bureaucrats. Our mission to

Food for thought - Gold Standard and XRP – The Potential for a New Financial System? tinyurl.com/mrkfvh6s

Patient advocacy groups are now reaching out. Voices will be heard..from those with bladder cancer to pancreatic cancer to lung cancer to brain tumors ..cancer is a war against time.

Some deeper understanding regarding Trumps strange actions with Epstein, etc.

Congratulations Dr. Soon-Shiong and the entire ImmunityBio team! Another approval of many more to come! Lead the way!!! ir.immunitybio.com/news-releases/…

$IBRX We are seing good volume today, and the share price is going up. This means investors are buying ImmunityBio. Let's see what we can read from the chart. 1. Since the low in May we have seen two "higher lows" and two "higher highs", which is bullish. There would have to

Let me see if I have this right... I'm illegally in a country and am given two Options: 1. $1,000 cash and a free plane ticket home. 2. A Florida swamp hotel room with 33 others who weren't smart enough to choose Option 1. Kind of a rhetorical option question...

After the Megyn Kelly interview with Dr. Pat Soon-Shiong about Bioshield (Anktiva), thankfully, people have learned more about this most promising cancer treatment. What many aren't aware of is that Dr. Pat's company is publicly traded under the symbol $IBRX. One way to support

I’ve built a system that can spot moves before they happen. SMCI spotted before the explosive 8% move for $10K today. I'm sending out the system with a Video guide. Like + Comment "SMCI" and I'll DM it to you.

NPR’s CEO Katherine Maher on CNN this morning: “As far as the accusations that we’re biased, I’d stand up and say, ‘Please show me a story that concerns you.’” I’ve got a few: 🧵 (1/5)

Just received this text yesterday from my friend Joe who saw the video on Anktiva "I'm almost in tears, Justin has been my friend for decades. Thank you so very much" Anktiva, the Cancer Bioshield. This is why we do what we do.

🚨BREAKING PART TWO: Bill Barr Held Secret Meetings to Plot Prosecutions of Trump and Block His Political Comeback “Bill Barr was like, ‘We should bring RICO because it's a very difficult type of charge to defend.’” - Patrícia Lélis, Whistleblower “You took my documents and

Trump ain’t playing games in DC! If you break the law, you will be locked up! Listen to this man that lives in DC, it’s not a game anymore!! 👊

Scott Baio is a big fan of Greg Gutfeld and he’s a little upset with Tyrus! Tyrus had mentioned that he’s seen so little of Scott lately that he didn’t know if he was alive or dead! Wait to you hear why we haven’t seen much of him since 2016!

*Senator Harry Reid given a few days to live prior to meeting Dr Shiong&Bioshield* DR. SHIONG: Senator Reid, who came to see me after having failed all other treatment with his pancreatic cancer spread to his liver, came to see me and he said to me, “Patrick, I’m here. But I

We’ve announced that our initial data shows 100% disease control in 5 out of 5 patients with recurrent glioblastoma after being treated with our ANKTIVA, NK cell therapy plus the Optune Gio® device. Read more: immunitybio.com/initial-data-s…

🚨 BREAKING: CDC Director Susan Monarez has been OUSTED by RFK Jr. after she attempted to push for the COVID vaccine, per multiple reports Multiple other top CDC officials are out as well, as they too complained about rescinding approvals for the vaccine Good riddance! 👋🏻

varunesh salt spring - Google Search google.ca/search?client=…

NEW CANCER DRUG ANKTIVA STRONGLY INCREASES OVERALL SURVIVAL OF TERMINAL LUNG CANCER PATIENTS Data from a completed clinical trial shows that lung cancer patients who have failed all FDA approved options—chemo, radiation, and checkpoint inhibitors—and have no more treatments